These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Treatment of the residual retroperitoneal mass after chemotherapy for advanced seminoma.
    Author: Ellison MF, Mostofi FK, Flanigan RC.
    Journal: J Urol; 1988 Sep; 140(3):618-20. PubMed ID: 3411688.
    Abstract:
    Although resection of the residual retroperitoneal mass after chemotherapy for nonseminomatous testicular cancer is standard practice, controversy exists as to the appropriate management of the residual mass after chemotherapy for advanced seminoma. A literature review suggests that 15 to 25 per cent of such masses will contain residual cancer, suggesting that retroperitoneal lymph node dissection is appropriate in these patients.
    [Abstract] [Full Text] [Related] [New Search]